loading
Schlusskurs vom Vortag:
$11.18
Offen:
$11.48
24-Stunden-Volumen:
62,959
Relative Volume:
0.59
Marktkapitalisierung:
$295.58M
Einnahmen:
$59,000
Nettoeinkommen (Verlust:
$-21.81M
KGV:
-1.0281
EPS:
-10.9518
Netto-Cashflow:
$-18.07M
1W Leistung:
-9.49%
1M Leistung:
-22.93%
6M Leistung:
+5.33%
1J Leistung:
+25.67%
1-Tages-Spanne:
Value
$11.04
$11.55
1-Wochen-Bereich:
Value
$11.02
$13.07
52-Wochen-Spanne:
Value
$7.05
$17.15

Benitec Biopharma Inc Stock (BNTC) Company Profile

Name
Firmenname
Benitec Biopharma Inc
Name
Telefon
(510) 780-0819
Name
Adresse
3940 TRUST WAY, HAYWARD, CA
Name
Mitarbeiter
16
Name
Twitter
@BenitecLtd
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
BNTC's Discussions on Twitter

Vergleichen Sie BNTC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
BNTC
Benitec Biopharma Inc
11.26 326.56M 59,000 -21.81M -18.07M -10.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-07 Eingeleitet TD Cowen Buy
2024-12-16 Eingeleitet H.C. Wainwright Buy
2024-12-13 Eingeleitet Robert W. Baird Outperform
2024-10-16 Eingeleitet Oppenheimer Outperform
2024-09-12 Eingeleitet Guggenheim Buy
2024-07-22 Eingeleitet Leerink Partners Outperform
2024-06-13 Eingeleitet Piper Sandler Overweight
2020-10-05 Herabstufung Ladenburg Thalmann Buy → Neutral
2020-04-20 Eingeleitet Ladenburg Thalmann Buy
2016-02-26 Herabstufung Maxim Group Buy → Hold
2015-12-31 Bestätigt Maxim Group Buy
2015-09-16 Bestätigt Maxim Group Buy
Alle ansehen

Benitec Biopharma Inc Aktie (BNTC) Neueste Nachrichten

pulisher
Jul 22, 2025

What drives Benitec Biopharma Inc. stock priceRapidly growing investment returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Benitec Biopharma Inc. Stock Analysis and ForecastFree Stock Market Forecast Reports - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Benitec Biopharma Inc. stockOutstanding growth strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Benitec Biopharma Inc. stock attracts strong analyst attentionSteady Income Ideas - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Is Benitec Biopharma Inc. a good long term investmentConsistently exceptional gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

(BNTC) Investment Report - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 18, 2025

Does Benitec Biopharma Inc. stock pay reliable dividendsFree Investment Community - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of “Buy” by Analysts - Defense World

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Benitec Biopharma Inc. stock outlookSmart High Yield Swing Trades - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise amid trial progress - Investing.com Australia

Jul 17, 2025
pulisher
Jul 15, 2025

How Benitec Biopharma Inc. stock performs during market volatilityFree Stock Market Entry & Exit Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Benitec Biopharma Inc. stock price move sharplyTriple Digit Return Forecasts - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Citizens JMP Reaffirms Their Buy Rating on Benitec Biopharma (BNTC) - The Globe and Mail

Jul 11, 2025
pulisher
Jul 10, 2025

Benitec BioPharma stock maintains Market Outperform rating at JMP By Investing.com - Investing.com Canada

Jul 10, 2025
pulisher
Jul 10, 2025

Benitec completes first cohort in gene therapy trial, advances to next phase By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

When the Price of (BNTC) Talks, People Listen - news.stocktradersdaily.com

Jul 09, 2025
pulisher
Jul 09, 2025

Benitec Biopharma Advances BB-301 Clinical Study - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

Benitec Biopharma Provides Operational Updates - GlobeNewswire

Jul 09, 2025
pulisher
Jul 09, 2025

Benitec Biopharma Inc. Provides Operational Updates - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

Benitec Biopharma (BNTC) Moves Forward with Clinical Study Enrollment | BNTC Stock News - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Benitec completes first cohort in gene therapy trial, advances to next phase - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

Benitec's BB-301 Gene Therapy Achieves Key Safety Milestone, Phase 1b/2a Trial Set to Expand - Stock Titan

Jul 09, 2025
pulisher
Jul 08, 2025

Benitec Biopharma (NASDAQ:BNTC) Now Covered by Analysts at TD Cowen - Defense World

Jul 08, 2025

Finanzdaten der Benitec Biopharma Inc-Aktie (BNTC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Benitec Biopharma Inc-Aktie (BNTC) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
SUVRETTA CAPITAL MANAGEMENT, L
Director
Mar 26 '25
Buy
13.00
900,000
11,700,000
8,793,245
BUCHI J KEVIN
Director
Feb 27 '25
Option Exercise
3.86
51,813
199,998
103,910
SUVRETTA CAPITAL MANAGEMENT, L
Director
Dec 23 '24
Buy
10.98
27,502
301,972
7,981,725
SUVRETTA CAPITAL MANAGEMENT, L
Director
Dec 24 '24
Buy
11.25
20,018
225,202
7,999,455
SUVRETTA CAPITAL MANAGEMENT, L
Director
Dec 03 '24
Buy
9.60
42,000
403,200
7,957,365
SUVRETTA CAPITAL MANAGEMENT, L
Director
Nov 20 '24
Buy
10.22
27,436
280,396
7,920,175
SUVRETTA CAPITAL MANAGEMENT, L
Director
Nov 19 '24
Buy
9.73
14,000
136,220
7,895,815
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):